Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Alkermes plc - Ordinary Shares (NQ:ALKS)

28.40 +1.20 (+4.41%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Alkermes plc - Ordinary Shares

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
News headline image
Recovery Month Renews Focus on Diagnosis, Treatment of Substance Use Disorder
SOURCE: Alkermes 
Via 3BL Media
Topics Death
News headline image
Ligand Pharmaceuticals Stock Shows Market Leadership With Jump To 82 RS Rating ↗
Ligand Pharmaceuticals stock saw a positive improvement to its Relative Strength (RS) Rating on Monday, rising from 71 to 82. 
Via Investor's Business Daily
News headline image
I-Mab Stock Joins Rank Of Stocks With RS Ratings Over 90 ↗
Looking for the best stocks to buy? Focus on those with rising relative strength such as I-Mab stock, which saw a (RS) Rating upgrade to 93. 
Via Investor's Business Daily
News headline image
Alkermes Associate Director Discusses How Her Personal Journey With Ovarian Cancer Influences Her Work
SOURCE: Alkermes 
Via 3BL Media
News headline image
Alkermes Announces Launch of 4th Annual Alkermes Pathways Research Awards® Program
SOURCE: Alkermes 
Via 3BL Media
News headline image
Wellness Tips for Cancer Patients
SOURCE: Alkermes 
Via 3BL Media
News headline image
Alkermes - Pick Of The Day ↗
Revenue is expected to grow 12.80% this year and another 8.60% next year. Earnings are estimated to increase 46.50% this year and another 77.80% next year. 
Via Talk Markets
News headline image
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
News headline image
Benzinga's Bulls And Bears Of The Week: Alibaba, Apple, Nio, PayPal, Verizon And More ↗
Benzinga has examined the prospects for many investor 
Via Benzinga
News headline image
BofA Downgrades Alkermes After Stock Rally: 'We Don't See A Favorable Catalyst Pathway' ↗
Following the recent rally, Alkermes Plc’s (NASDAQ:ALKS 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 2, 2021 ↗
Upgrades For Okta Inc (NASDAQ: 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Gainers Plus Therapeutics (NASDAQ:PSTV) shares increased by 22.1% to $2.32 during Thursday's pre-market session. The company's market cap stands at $28.0 million.... 
Via Benzinga
Unusual Options Activity Insight: Alkermes ↗
Alkermes (NASDAQ:ALKS) shares experienced unusual options... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
Understanding Alkermes's Unusual Options Activity ↗
Alkermes (NASDAQ:ALKS) shares experienced unusual options... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 31) AC Immune SA (NASDAQ: ACIU... 
Via Benzinga
News headline image
Alkermes Sr. Director of Oncology Discusses Career, Inspirational Women in STEM
SOURCE: Alkermes 
Via 3BL Media
News headline image
Alkermes Shortlisted for 2021 Ibec KeepWell Awards
SOURCE: Alkermes 
Via 3BL Media
News headline image
The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)... 
Via Benzinga
News headline image
Know When To Hold 'Em, Know When To Fold 'Em ... ↗
A long Monday list identifying some sensible and some impenetrable moves behind today's market in our stocks. 
Via Talk Markets
News headline image
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)... 
Via Benzinga
Topics Intellectual Property
News headline image
Return on Capital Employed Insights for Alkermes ↗
After pulling data from Benzinga Pro it seems like during Q2, Alkermes's (NASDAQ:ALKS) reported sales totaled $303.72 million. Despite a 26.9% in earnings, the company posted a... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 23) AbbVie Inc. (NYSE: ABBV) (... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Highs On Monday ↗
Before 10 a.m. ET on Monday, 119 companies hit new 52-week highs. Noteables: The largest company by market cap to set a new 52-week high was Alphabet (NASDAQ:GOOG... 
Via Benzinga
News headline image
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.